相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A phase II study of dose-dense temozolomide and lapatinib for recurrent low-grade and anaplastic supratentorial, infratentorial, and spinal cord ependymoma
Mark R. Gilbert et al.
NEURO-ONCOLOGY (2021)
Gene regulation by long non-coding RNAs and its biological functions
Luisa Statello et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2021)
Local and systemic therapy of recurrent ependymoma in children and adolescents: short- and long-term results of the E-HIT-REZ 2005 study
Jonas E. Adolph et al.
NEURO-ONCOLOGY (2021)
Ultra high-risk PFA ependymoma is characterized by loss of chromosome 6q
Lorena Baroni et al.
NEURO-ONCOLOGY (2021)
Characterization of molecular signatures of supratentorial ependymomas
Matthew Torre et al.
MODERN PATHOLOGY (2020)
Molecular characterization of histopathological ependymoma variants
Julia E. Neumann et al.
ACTA NEUROPATHOLOGICA (2020)
TET2 promotor methylation and TET2 protein expression in pediatric posterior fossa ependymoma
Daniela Pierscianek et al.
NEUROPATHOLOGY (2020)
Multiplatform Molecular Profiling Reveals Epigenomic Intratumor Heterogeneity in Ependymoma
S. John Liu et al.
CELL REPORTS (2020)
Metabolic Regulation of the Epigenome Drives Lethal Infantile Ependymoma
Kulandaimanuvel Antony Michealraj et al.
CELL (2020)
Characterization of global 5-hydroxymethylcytosine in pediatric posterior fossa ependymoma
Tao Wu et al.
CLINICAL EPIGENETICS (2020)
Locoregional delivery of CAR T cells to the cerebrospinal fluid for treatment of metastatic medulloblastoma and ependymoma
Laura K. Donovan et al.
NATURE MEDICINE (2020)
Single-Cell RNA-Seq Reveals Cellular Hierarchies and Impaired Developmental Trajectories in Pediatric Ependymoma
Johannes Gojo et al.
CANCER CELL (2020)
C11orf95-RELA reprograms 3D epigenome in supratentorial ependymoma
Jacqueline Jufen Zhu et al.
ACTA NEUROPATHOLOGICA (2020)
A retrospective analysis of recurrent pediatric ependymoma reveals extremely poor survival and ineffectiveness of current treatments across central nervous system locations and molecular subgroups
Timothy A. Ritzmann et al.
PEDIATRIC BLOOD & CANCER (2020)
Single-Cell RNA Sequencing of Childhood Ependymoma Reveals Neoplastic Cell Subpopulations That Impact Molecular Classification and Etiology
Austin E. Gillen et al.
CELL REPORTS (2020)
EPEN-54. ACNS0831, PHASE III RANDOMIZED TRIAL OF POST-RADIATION CHEMOTHERAPY IN PATIENTS WITH NEWLY DIAGNOSED EPENDYMOMA AGES 1 TO 21 YEARS
Amy Smith et al.
NEURO-ONCOLOGY (2020)
Genetic predisposition to longer telomere length and risk of childhood, adolescent and adult-onset ependymoma
Chenan Zhang et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2020)
Brain immunology and immunotherapy in brain tumours
John H. Sampson et al.
NATURE REVIEWS CANCER (2020)
The blood-brain barrier and blood-tumour barrier in brain tumours and metastases
Costas D. Arvanitis et al.
NATURE REVIEWS CANCER (2020)
Childhood supratentorial ependymomas with YAP1-MAMLD1 fusion: an entity with characteristic clinical, radiological, cytogenetic and histopathological features
Felipe Andreiuolo et al.
BRAIN PATHOLOGY (2019)
Survival and functional outcomes of molecularly defined childhood posterior fossa ependymoma: Cure at a cost
Michal Zapotocky et al.
CANCER (2019)
Conformal Radiation Therapy for Pediatric Ependymoma, Chemotherapy for Incompletely Resected Ependymoma, and Observation for Completely Resected, Supratentorial Ependymoma
Thomas E. Merchant et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
EZHIP/CXorf67 mimics K27M mutated oncohistones and functions as an intrinsic inhibitor of PRC2 function in aggressive posterior fossa ependymoma
Jens-Martin Huebner et al.
NEURO-ONCOLOGY (2019)
Childhood cerebellar tumours mirror conserved fetal transcriptional programs
Maria C. Vladoiu et al.
NATURE (2019)
PFA ependymoma-associated protein EZHIP inhibits PRC2 activity through a H3 K27M-like mechanism
Siddhant U. Jain et al.
NATURE COMMUNICATIONS (2019)
A role for ABCB1 in prognosis, invasion and drug resistance in ependymoma
Durgagauri H. Sabnis et al.
SCIENTIFIC REPORTS (2019)
MYCN amplification drives an aggressive form of spinal ependymoma
David R. Ghasemi et al.
ACTA NEUROPATHOLOGICA (2019)
Clinicopathological evaluation of PD-L1 expression and cytotoxic T-lymphocyte infiltrates across intracranial molecular subgroups of ependymomas: are these tumors potential candidates for immune check-point blockade?
Aruna Nambirajan et al.
BRAIN TUMOR PATHOLOGY (2019)
Downregulated long non-coding RNA LINC00899 inhibits invasion and migration of spinal ependymoma cells via RBL2-dependent FoxO pathway
Qun-Bang Chen et al.
CELL CYCLE (2019)
A systematic review and meta-analysis of outcomes in pediatric, recurrent ependymoma
Lennox Byer et al.
JOURNAL OF NEURO-ONCOLOGY (2019)
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012-2016
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2019)
YAP1 subgroup supratentorial ependymoma requires TEAD and nuclear factor I-mediated transcriptional programmes for tumorigenesis
Kristian W. Pajtler et al.
NATURE COMMUNICATIONS (2019)
Tumor-infiltrating immune cell subpopulations and programmed death ligand 1 (PD-L1) expression associated with clinicopathological and prognostic parameters in ependymoma
Soo Jeong Nam et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)
Neurocognitive, academic and functional outcomes in survivors of infant ependymoma (UKCCSG CNS 9204)
Matthew C. H. J. Morrall et al.
CHILDS NERVOUS SYSTEM (2019)
Genomic Landscape of Intramedullary Spinal Cord Gliomas
Ming Zhang et al.
SCIENTIFIC REPORTS (2019)
EANO guidelines for the diagnosis and treatment of ependymal tumors
Roberta Ruda et al.
NEURO-ONCOLOGY (2018)
Significance of cyclin D1 overexpression in progression and radio-resistance of pediatric ependymomas
Muh-Lii Liang et al.
ONCOTARGET (2018)
Molecular heterogeneity and CXorf67 alterations in posterior fossa group A (PFA) ependymomas
Kristian W. Pajtler et al.
ACTA NEUROPATHOLOGICA (2018)
Heterogeneity within the PF-EPN-B ependymoma subgroup
Florence M. G. Cavalli et al.
ACTA NEUROPATHOLOGICA (2018)
Patterns of relapse for children with localized intracranial ependymoma
Brian De et al.
JOURNAL OF NEURO-ONCOLOGY (2018)
C11orf95-RELA fusions and upregulated NF-KB signalling characterise a subset of aggressive supratentorial ependymomas that express L1CAM and nestin
Prit Benny Malgulwar et al.
JOURNAL OF NEURO-ONCOLOGY (2018)
Specific expression of PD-L1 in RELA-fusion supratentorial ependymoma: Implications for PD-1-targeted therapy
Davis A. Witt et al.
PEDIATRIC BLOOD & CANCER (2018)
A De Novo Mouse Model of C11orf95-RELA Fusion-Driven Ependymoma Identifies Driver Functions in Addition to NF-kappa B
Tatsuya Ozawa et al.
CELL REPORTS (2018)
Epithelial-to-mesenchymal transition related transcription factors are up-regulated in ependymomas and correlate with a poor prognosis
Prit Benny Malgulwar et al.
HUMAN PATHOLOGY (2018)
Significance of molecular classification of ependymomas: C11orf95-RELA fusion-negative supratentorial ependymomas are a heterogeneous group of tumors
Kohei Fukuoka et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2018)
The current consensus on the clinical management of intracranial ependymoma and its distinct molecular variants
Kristian W. Pajtler et al.
ACTA NEUROPATHOLOGICA (2017)
Prognostic relevance of miR-124-3p and its target TP53INP1 in pediatric ependymoma
Yulia Margolin-Miller et al.
GENES CHROMOSOMES & CANCER (2017)
Rethinking childhood ependymoma: a retrospective, multi-center analysis reveals poor long-term overall survival
Amanda E. Marinoff et al.
JOURNAL OF NEURO-ONCOLOGY (2017)
NF-κB upregulation through epigenetic silencing of LDOC1 drives tumor biology and specific immunophenotype in Group A ependymoma
Andrea M. Griesinger et al.
NEURO-ONCOLOGY (2017)
Telomerase activation in posterior fossa group A ependymomas is associated with dismal prognosis and chromosome 1q gain
Johannes Gojo et al.
NEURO-ONCOLOGY (2017)
p16 Loss and E2F/cell cycle deregulation in infant posterior fossa ependymoma
Seth C. Lummus et al.
PEDIATRIC BLOOD & CANCER (2017)
Transcriptomic analysis in pediatric spinal ependymoma reveals distinct molecular signatures
Anbarasu Lourdusamy et al.
ONCOTARGET (2017)
Novel SEC61G-EGFR Fusion Gene in Pediatric Ependymomas Discovered by Clonal Expansion of Stem Cells in Absence of Exogenous Mitogens
Tiziana Servidei et al.
CANCER RESEARCH (2017)
Immunohistochemical analysis of H3K27me3 demonstrates global reduction in group-A childhood posterior fossa ependymoma and is a powerful predictor of outcome
Pooja Panwalkar et al.
ACTA NEUROPATHOLOGICA (2017)
Clinical association analysis of ependymomas and pilocytic astrocytomas reveals elevated FGFR3 and FGFR1 expression in aggressive ependymomas
Birgitta Lehtinen et al.
BMC CANCER (2017)
Temozolomide as salvage treatment for recurrent intracranial ependymomas of the adult: a retrospective study
Roberta Ruda et al.
NEURO-ONCOLOGY (2016)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
A molecular biology and phase II study of imetelstat (GRN163L) in children with recurrent or refractory central nervous system malignancies: a pediatric brain tumor consortium study
Ralph Salloum et al.
JOURNAL OF NEURO-ONCOLOGY (2016)
Single-agent erlotinib versus oral etoposide in patients with recurrent or refractory pediatric ependymoma: a randomized open-label study
Regina I. Jakacki et al.
JOURNAL OF NEURO-ONCOLOGY (2016)
Supratentorial clear cell ependymomas with branching capillaries demonstrate characteristic clinicopathological features and pathological activation of nuclear factor-kappaB signaling
Dominique Figarella-Branger et al.
NEURO-ONCOLOGY (2016)
Lowered H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas
Jill Bayliss et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Phase II evaluation of sunitinib in the treatment of recurrent or refractory high-grade glioma or ependymoma in children: a children's Oncology Group Study ACNS1021
Cynthia Wetmore et al.
CANCER MEDICINE (2016)
Molecular Classification of Ependymal Tumors across All CNS Compartments, Histopathological Grades, and Age Groups
Kristian W. Pajtler et al.
CANCER CELL (2015)
Spinal Myxopapillary Ependymomas Demonstrate a Warburg Phenotype
Stephen C. Mack et al.
CLINICAL CANCER RESEARCH (2015)
An open-label, two-stage, phase II study of bevacizumab and lapatinib in children with recurrent or refractory ependymoma: a collaborative ependymoma research network study (CERN)
Mariko DeWire et al.
JOURNAL OF NEURO-ONCOLOGY (2015)
An in vivo screen identifies ependymoma oncogenes and tumor-suppressor genes
Kumarasamypet M. Mohankumar et al.
NATURE GENETICS (2015)
Expression alterations define unique molecular characteristics of spinal ependymomas
Anbarasu Lourdusamy et al.
ONCOTARGET (2015)
EphB2 activation is required for ependymoma development as well as inhibits differentiation and promotes proliferation of the transformed cell
Phylip Chen et al.
Scientific Reports (2015)
Interleukin-6/STAT3 Pathway Signaling Drives an Inflammatory Phenotype in Group A Ependymoma
Andrea M. Griesinger et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Clinical course and progression-free survival of adult intracranial and spinal ependymoma patients
Elizabeth Vera-Bolanos et al.
NEURO-ONCOLOGY (2015)
Growth-Factor-Driven Rescue to Receptor Tyrosine Kinase (RTK) Inhibitors through Akt and Erk Phosphorylation in Pediatric Low Grade Astrocytoma and Ependymoma
Mariska Sie et al.
PLOS ONE (2015)
Molecular sub-group-specific immunophenotypic changes are associated with outcome in recurrent posterior fossa ependymoma
Lindsey M. Hoffman et al.
ACTA NEUROPATHOLOGICA (2014)
Telomerase inhibition abolishes the tumorigenicity of pediatric ependymoma tumor-initiating cells
Mark Barszczyk et al.
ACTA NEUROPATHOLOGICA (2014)
Epigenetic genome-wide analysis identifies BEX1 as a candidate tumour suppressor gene in paediatric intracranial ependymoma
Katherine Karakoula et al.
CANCER LETTERS (2014)
Study of chromosome 9q gain, Notch pathway regulators and Tenascin-C in ependymomas
Rakesh Kumar Gupta et al.
JOURNAL OF NEURO-ONCOLOGY (2014)
Epigenomic alterations define lethal CIMP-positive ependymomas of infancy
S. C. Mack et al.
NATURE (2014)
C11orf95-RELA fusions drive oncogenic NF-κB signalling in ependymoma
Matthew Parker et al.
NATURE (2014)
Ependymoma stem cells are highly sensitive to temozolomide in vitro and in orthotopic models
Daniela Meco et al.
NEURO-ONCOLOGY (2014)
Axl/Gas6/NFκB signalling in schwannoma pathological proliferation, adhesion and survival
S. Ammoun et al.
ONCOGENE (2014)
PI3K Pathway Activation Provides a Novel Therapeutic Target for Pediatric Ependymoma and Is an Independent Marker of Progression-Free Survival
Hazel A. Rogers et al.
CLINICAL CANCER RESEARCH (2013)
Role of platelet derived growth factor receptor (PDGFR) over-expression and angiogenesis in ependymoma
Lucas Moreno et al.
JOURNAL OF NEURO-ONCOLOGY (2013)
A prognostic gene expression signature in infratentorial ependymoma
Khalida Wani et al.
ACTA NEUROPATHOLOGICA (2012)
Nestin Expression Identifies Ependymoma Patients with Poor Outcome
Till Milde et al.
BRAIN PATHOLOGY (2012)
Effects of epidermal growth factor receptor blockade on ependymoma stem cells in vitro and in orthotopic mouse models
Tiziana Servidei et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Lack of efficacy of bevacizumab plus irinotecan in cases of pediatric recurrent ependymoma - a Pediatric Brain Tumor Consortium study
Sridharan Gururangan et al.
NEURO-ONCOLOGY (2012)
Delineation of Two Clinically and Molecularly Distinct Subgroups of Posterior Fossa Ependymoma
Hendrik Witt et al.
CANCER CELL (2011)
Apurinic/apyrimidinic endonuclease is inversely associated with response to radiotherapy in pediatric ependymoma
Michael S. Bobola et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
UBE4B promotes Hdm2-mediated degradation of the tumor suppressor p53
Hong Wu et al.
NATURE MEDICINE (2011)
Epidermal growth factor receptor and caveolin-1 coexpression identifies adult supratentorial ependymomas with rapid unfavorable outcomes
Rebecca Senetta et al.
NEURO-ONCOLOGY (2011)
Identification of MicroRNAs as Potential Prognostic Markers in Ependymoma
Fabricio F. Costa et al.
PLOS ONE (2011)
PARP inhibition sensitizes childhood high grade glioma, medulloblastoma and ependymoma to radiation
Dannis G. van Vuurden et al.
ONCOTARGET (2011)
Telomerase Inhibition as a Novel Therapy for Pediatric Ependymoma
Vincent C. H. Wong et al.
BRAIN PATHOLOGY (2010)
EDG3 and SHC3 on chromosome 9q22 are co-amplified in human ependymomas
Lorenzo Magrassi et al.
CANCER LETTERS (2010)
Molecular Staging of Intracranial Ependymoma in Children and Adults
Andrey Korshunov et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Tumor vessel biology in pediatric intracranial ependymoma Clinical article
Michiel Wagemakers et al.
JOURNAL OF NEUROSURGERY-PEDIATRICS (2010)
Cross-species genomics matches driver mutations and cell compartments to model ependymoma
Robert A. Johnson et al.
NATURE (2010)
A clinically relevant orthotopic xenograft model of ependymoma that maintains the genomic signature of the primary tumor and preserves cancer stem cells in vivo
Litian Yu et al.
NEURO-ONCOLOGY (2010)
Neuronal differentiation distinguishes supratentorial and infratentorial childhood ependymomas
Felipe Andreiuolo et al.
NEURO-ONCOLOGY (2010)
Temozolomide for Recurrent Intracranial Supratentorial Platinum-Refractory Ependymoma
Marc C. Chamberlain et al.
CANCER (2009)
Candidate Genes on Chromosome 9q33-34 Involved in the Progression of Childhood Ependymomas
Stephanie Puget et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Immune Gene and Cell Enrichment Is Associated with a Good Prognosis in Ependymoma
Andrew M. Donson et al.
JOURNAL OF IMMUNOLOGY (2009)
Incidence patterns for ependymoma: a Surveillance, Epidemiology, and End Results study Clinical article
Courtney S. McGuire et al.
JOURNAL OF NEUROSURGERY (2009)
Pediatric Ependymoma: Biological Perspectives
John-Paul Kilday et al.
MOLECULAR CANCER RESEARCH (2009)
Telomere maintenance and dysfunction predict recurrence in paediatric ependymoma
U. Tabori et al.
BRITISH JOURNAL OF CANCER (2008)
Merlin is apotent inhibitor of glioma growth
Ying-Ka Ingar Lau et al.
CANCER RESEARCH (2008)
O6-Methylguanine-DNA-Methyltransferase in recurring anaplastic ependymomas: PCR and immunohistochemistry
A. M. Buccoliero et al.
JOURNAL OF CHEMOTHERAPY (2008)
Prognostic value of tumor microinvasion and metalloproteinases expression in intracranial pediatric ependymomas
Matija Snuderl et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2008)
Primary postoperative chemotherapy without radiotherapy for intracranial ependymoma in children: the UKCCSG/SIOP prospective study
Richard G. Grundy et al.
LANCET ONCOLOGY (2007)
Expression of cyclo-oxygenase-2 in ependymal tumors
Andres A. Roma et al.
NEUROPATHOLOGY (2006)
Human telomere reverse transcriptase expression predicts progression and survival in pediatric intracranial ependymoma
U Tabori et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Identification of gains on 1q and epidermal growth factor receptor overexpression as independent prognostic markers in intracranial ependymoma
F Mendrzyk et al.
CLINICAL CANCER RESEARCH (2006)
Radial glia cells are candidate stem cells of ependymoma
MD Taylor et al.
CANCER CELL (2005)
Epigenetic inactivation of the RASSF1A tumour suppressor gene in ependymoma
DW Hamilton et al.
CANCER LETTERS (2005)
Alterations of protein 4.1 family members in ependymomas: a study of 84 cases
V Rajaram et al.
MODERN PATHOLOGY (2005)
Vascularization and expression of hypoxia-related tissue factors in intracranial ependymoma and their impact on patient survival
M Preusser et al.
ACTA NEUROPATHOLOGICA (2005)
Analysis of HIC-1 methylation and transcription in human ependymomas
A Waha et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
9p21 and 13q14 dosages in ependymomas. A clinicopathologic study of 101 cases
V Rajaram et al.
MODERN PATHOLOGY (2004)
CDKN2A, CDKN2B and p14(ARF) are frequently and differentially methylated in ependymal tumours
E Rousseau et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2003)
Amplification and overexpression of mdm2 gene in ependymomas
SO Suzuki et al.
MODERN PATHOLOGY (2000)
The effects of exogenous growth factors on matrix metalloproteinase secretion by human brain tumour cells
HK Rooprai et al.
BRITISH JOURNAL OF CANCER (2000)
分享论文
